Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Want to read this story later
The queries for the articles about mechanism of GLP-1RAs in liver disease and the clinical experiments: ((GLP-1RAs[Title/Abstract]) OR (GLP-1R agonists[Title/Abstract]) OR (GLP-1 receptor agonists[Title/Abstract]) OR (GLP-1 receptor[Title/Abstract])) AND ((liver[Title/Abstract]) OR (hepatic[Title/Abstract]) OR (HCC[Title/Abstract]) OR (fibrosis[Title/Abstract]) OR (cirrhosis[Title/Abstract]) OR (NAFLD[Title/Abstract]) OR (MASLD[Title/Abstract])) AND ((inflammation[Title/Abstract]) OR (immun*[Title/Abstract]) OR (T cell[Title/Abstract]) OR (B cell[Title/Abstract]) OR (NK cell[Title/Abstract]) OR (macrophage[Title/Abstract]))
IGF-1 and cardiovascular disease [PMID: 30735831] Laboratory literature summary: IGF-1 and cardiovascular disease
E., Kanikarla-Marie, P
The standard semaglutide dosing schedule follows a gradual escalation from 0.25mg to 2.4mg over 16 to 20 weeks
Zhang QY, et al
US$ 28.20
US$ 24.60
US$ 26.41
US$ 21.29
US$ 20.66
US$ 29.28
US$ 20.45
US$ 22.69
